Blog

Sep 29, 2024, 15:21

Joe Y Chang: Intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC

Joe Y Chang, Professor and Director, Stereotactic Ablative Radiotherapy Program, MD Anderson Cancer Center, shared a post on X:

“MD Anderson finished all enrollment of phase II randomized study comparing intensity-modulated proton vs photon therapy with concurrent chemo in medical inoperable stage III NSCLC.

I am lucky enough to enroll the last pt and received a nice bottle of wine from Zhongxing Liao.”

Source: Joe Y Chang/X

cancer cancer awareness cancer care fight against cancer Global fight against cancer Joe Y Chang MD Anderson Cancer Center NSCLC OncoDaily Oncology Zhongxing Liao

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC